These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 35418770)
1. Erratum: A Prospective, Open-Label Study to Evaluate the Impact of VYC-12L Injection on Skin Quality Attributes in Healthy Volunteers [Corrigendum]. Clin Cosmet Investig Dermatol; 2022; 15():585-586. PubMed ID: 35418770 [TBL] [Abstract][Full Text] [Related]
2. A Prospective, Open-Label Study to Evaluate the Impact of VYC-12L Injection on Skin Quality Attributes in Healthy Volunteers. Safa M; Natalizio A; Hee CK Clin Cosmet Investig Dermatol; 2022; 15():411-426. PubMed ID: 35300433 [TBL] [Abstract][Full Text] [Related]
3. Improvements in Skin Quality Biological Markers in Skin Explants Using Hyaluronic Acid Filler VYC-12L. Nakab L; Hee CK; Guetta O Plast Reconstr Surg Glob Open; 2020 Mar; 8(3):e2723. PubMed ID: 32537370 [TBL] [Abstract][Full Text] [Related]
4. Expert Consensus on Injection Technique and Area-Specific Recommendations for the Hyaluronic Acid Dermal Filler VYC-12L to Treat Fine Cutaneous Lines. Ogilvie P; Thulesen J; Leys C; Sykianakis D; Chantrey J; Safa M; Figueiredo V; Heydenrych I; Cavallini M; Langeland EK; Wetter A Clin Cosmet Investig Dermatol; 2020; 13():267-274. PubMed ID: 32308460 [TBL] [Abstract][Full Text] [Related]
5. Erratum: A Dermocosmetic Significantly Reduces the Frequency and Intensity of Facial Skin Intolerability and Sensitivity in Subjects with Skin Intolerant to Skin Care Products and Sensitive Skin [Corrigendum]. Clin Cosmet Investig Dermatol; 2023; 16():3053-3055. PubMed ID: 37905196 [TBL] [Abstract][Full Text] [Related]
6. Erratum: Association Between the Diabetic Foot Ulcer and the Bacterial Colony of the Skin Based on 16S rRNA Gene Sequencing: An Observational Study [Corrigendum]. Clin Cosmet Investig Dermatol; 2024; 17():1809-1810. PubMed ID: 39132028 [TBL] [Abstract][Full Text] [Related]
7. Erratum: PD-L1 Biomolecules Associated with Clinical Features in Non-Melanoma Skin Cancer [Corrigendum]. Clin Cosmet Investig Dermatol; 2023; 16():1071-1072. PubMed ID: 37114035 [TBL] [Abstract][Full Text] [Related]
9. Skin Quality Improvement With VYC-12, a New Injectable Hyaluronic Acid: Objective Results Using Digital Analysis. Cavallini M; Papagni M; Ryder TJ; Patalano M Dermatol Surg; 2019 Dec; 45(12):1598-1604. PubMed ID: 30893167 [TBL] [Abstract][Full Text] [Related]
10. Erratum: Vitamin D Levels in Patients with and without Acne and Its Relation to Acne Severity: A Case-Control Study [Corrigendum]. Clin Cosmet Investig Dermatol; 2020; 13():815. PubMed ID: 33173322 [TBL] [Abstract][Full Text] [Related]
11. Erratum: A Clinical Investigation of the Performance and Safety of Epaderm®, an Emollient Cream [Corrigendum]. Clin Cosmet Investig Dermatol; 2021; 14():1173-1174. PubMed ID: 34526795 [TBL] [Abstract][Full Text] [Related]
12. Erratum: A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab [Corrigendum]. Clin Cosmet Investig Dermatol; 2024; 17():1447-1448. PubMed ID: 38911339 [TBL] [Abstract][Full Text] [Related]
13. Erratum: Efficacy and Safety of Resilient Hyaluronic Acid Fillers Injected with a Cannula: A Randomized, Evaluator-Blinded, Split-Face Controlled Study [Corrigendum]. Clin Cosmet Investig Dermatol; 2023; 16():1763-1764. PubMed ID: 37441696 [TBL] [Abstract][Full Text] [Related]
14. Erratum: The 10-Point Plan 2021: Updated Concepts for Improved Procedural Safety During Facial Filler Treatments [Corrigendum]. Clin Cosmet Investig Dermatol; 2021; 14():1601-1602. PubMed ID: 34754210 [TBL] [Abstract][Full Text] [Related]
15. Erratum: The One21 Technique: An Individualized Treatment for Glabellar Lines Based on Clinical and Anatomical Landmarks [Corrigendum]. Clin Cosmet Investig Dermatol; 2021; 14():355. PubMed ID: 33854353 [TBL] [Abstract][Full Text] [Related]
16. Erratum: From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB) [Corrigendum]. Clin Cosmet Investig Dermatol; 2021; 14():679. PubMed ID: 34188510 [TBL] [Abstract][Full Text] [Related]
17. Erratum: Recalcitrant Reactive Perforating Collagenosis Successfully Treated with Dupilumab: A Case Report [Corrigendum]. Clin Cosmet Investig Dermatol; 2024; 17():1585-1586. PubMed ID: 38984320 [TBL] [Abstract][Full Text] [Related]
18. Erratum: Potential Role of Tranexamic Acid in Rosacea Treatment: Conquering Flushing Beyond Melasma [Corrigendum]. Clin Cosmet Investig Dermatol; 2024; 17():1551-1552. PubMed ID: 38952412 [TBL] [Abstract][Full Text] [Related]
19. Improvements in satisfaction with skin after treatment of facial fine lines with VYC-12 injectable gel: Patient-reported outcomes from a prospective study. Ogilvie P; Safa M; Chantrey J; Leys C; Cavallini M; Niforos F; Hopfinger R; Marx A J Cosmet Dermatol; 2020 May; 19(5):1065-1070. PubMed ID: 31621189 [TBL] [Abstract][Full Text] [Related]
20. Erratum: Effect of Chloroquine on Type 2 Inflammatory Response in MC903-Induced Atopic Dermatitis Mice [Corrigendum]. Clin Cosmet Investig Dermatol; 2024; 17():1823-1826. PubMed ID: 39139847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]